German Diabetes Center
Düsseldorf, North Rhine-Westphalia, 40225, Germany
NCT Number: NCT01229059
This study aims to explore time-dependent effects of lipid infusion an intramyocellular lipid metabolites and the induction of impaired insulin signaling.
Looking for future studies?
Notify Me20 year–55 year
All sexes
Observational
Düsseldorf, North Rhine-Westphalia, 40225, Germany
Increased availability of free fatty acids impairs glucose disposal in young healthy humans. Patients with type 2 diabetes have reduced whole body glucose disposal, increased ectopic lipid deposition in skeletal muscle and the liver and impaired mitochondrial function. Recent studies suggest that lipid metabolites such as diacylglycerol (DAG), ceramides and long-chain acyl-coA represent the active mediators inducing insulin resistance. Possible targets are DAG-sensitive Proteinkinase C (PKC θ, PKC ε) which inhibit the insulin signaling cascade and ceramides which interfere with the insulin signaling cascade at Proteinkinase B/AKT. Prior studies raised controvesial evidence, thus, it is yet unclear, whether DAG or ceramides are the primary agents inducig lipid-induced insulin resistance. Therefore, the current study aims to explore the time course of the appearance of intramyocellular lipid compunds during lipid infusion in parallel assessing markers of impaired insulin action.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
For the athletes group additionally:
Exclusion criteria
Lipid enriched infusions will be applied for 2-6 hours.
Other names: soy oil
Time frame: after 4 hours lipid infusion
Muscle biopsies are taken before, after 2.5 and 4 hours of lipid infusion
Time frame: during lipid infusion
glycogen synthesis rate, glucose-6-phosphate
Time frame: after 4 hours lipid infusion
Mitochondrial function will bes assessed from muscle biopsy samples taken after 4 hours, insulin sensitivity will be assessed from hyperinsulinemic-euglycemic clamps following 4 hours lipid infusion
German Diabetes Center
Other
Assessment of the Time Course of Lipid Induced Insulin Resistance
Acronym: FFAIR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05251207
Glucose Metabolism Disorders, Hyperinsulinism
Poznan, Poland
View Trial DetailsNCT01809288
Behavior, Body Weight
Bethesda, Maryland, United States
View Trial DetailsNCT06205030
Diabetes Mellitus, Diabetes Mellitus, Type 2
Kerman, Iran
View Trial DetailsNCT05835999
Aging, Glucose Metabolism Disorders
Madison, Wisconsin, United States
View Trial Details